Listen to The Lancet Gastroenterology & Hepatology

Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.

Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.

Jennifer Flemming talks with The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease.

Graham Foster speaks with The Lancet Gastroenterology & Hepatology about his recent work on incentivising and supporting primary-care physicians to increase hepatitis screenings of migrant populations.

Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

Michele Reni speaks with The Lancet Gastroenterology & Hepatology about the PAXG regimen for treatment of pancreatic cancer.

Marco Carbone talks to The Lancet Gastroenterology & Hepatology about predicting treatment response for patients with primary biliary cholangitis

Marc Rothenberg joins The Lancet Gastroenterology & Hepatology to talk about eosinophilic oesophagitis endotype classification.

Homie Razavi and Devin Razavi-Shearer join The Lancet Gastroenterology & Hepatology to discuss their HBV modelling study.

Jasper Vleugels joins The Lancet Gastroenterology and Hepatology to discuss the results of the FIND-UC trial.